ASTELLAS GENE THERAPIES
Astellas Gene Therapies is a biotechnology company that develops new gene therapy treatments and medicines.
ASTELLAS GENE THERAPIES
Industry:
Biotechnology Genetics Health Care
Founded:
2012-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.astellasgenetherapies.com
Total Employee:
251+
Status:
Active
Contact:
(415) 818-1001
Email Addresses:
[email protected]
Technology used in webpage:
Euro Google Tag Manager Amazon Global Site Tag IPv6 Cloudflare Hosting Cloudflare CDN GoDaddy DNS AWS Global Accelerator Cloudflare Challenge
Similar Organizations
AUM LifeTech
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
Genus IntelliGen
Genus IntelliGen is a biotechnology company that specializes in applying science to animal genetic breeding improvement.
Phalanx Biotech
Phalanx biotech is a develops whole genome microarray, miRNA microarray and hybridization chamber.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Official Site Inspections
http://www.astellasgenetherapies.com Semrush global rank: 7.6 M Semrush visits lastest month: 727
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Astellas Gene Therapies"
About | Astellas Pharma Inc.
HR Vision, Talent and Organization Management; Engagement and Diversity, Equity & Inclusion; A living wage; Occupational Health & Safety; Promoting Health Management; Major Activities …See details»
Astellas Gene Therapies - Crunchbase Company Profile & Funding
Astellas Gene Therapies is a biotechnology company that develops new gene therapy treatments and medicines.See details»
Astellas Gene Therapies - Overview, News & Similar companies
Who is Astellas Gene Therapies. Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for pat ients. …See details»
ABOUT US - Astellas Gene Therapies
Research Facilities. Under construction and scheduled to be fully operational by the Summer of 2024, our new South San Francisco West Coast hub for Cell and Gene Therapy research will …See details»
Astellas Gene Therapies, Inc. - Drug pipelines, Patents, Clinical ...
Www.astellasgenetherapies.com. Public Company | Subsidiary Company | 2013 | California, United States | 250-500 | NASDAQ: BOLD | www.astellasgenetherapies.com. Last update 10 …See details»
News | Astellas Pharma Inc.
TOKYO, March 31, 2021 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas” ) today announced that it will further integrate its wholly owned …See details»
Astellas Gene Therapies, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Astellas Gene Therapies, Inc. of South San Francisco, CA. Get the latest business insights from Dun & …See details»
Astellas Gene Therapies | NCBioNetwork.org
Our investigational therapies target rare diseases through three modalities: gene replacement, exon skipping gene therapy and vectorized RNA knockdown.See details»
Astellas Gene Therapies - Craft
Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company committed to the development and commercialization of innovative new treatments for patients …See details»
Our Science - Astellas Gene Therapies
Our global infrastructure and strong collaboration across the organization allows us to combine research and manufacturing, creating opportunities to learn and apply knowledge and further …See details»
Astellas Celebrates the Opening of Its New Large-Scale Gene …
Jun 8, 2022 - 135,000 square-foot state-of-the-art gene therapy manufacturing facility located in Sanford, N.C., officially opened June 8 - Facility to support clinical- and commercial-scale …See details»
Astellas Home page | Astellas Pharma Inc.
Jun 13, 2025 Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable …See details»
Astellas Pharma : Establishes ' Gene Therapies' as its Global Gene ...
Apr 1, 2021 TOKYO - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., 'Astellas' ) today announced that it will further integrate its wholly owned subsidiary, …See details»
Astellas Gene Therapies Inc - Company Profile and News
Company profile page for Astellas Gene Therapies Inc including stock price, company news, executives, board members, and contact informationSee details»
News - Astellas Pharma Inc. - Astellas Gene Therapies
Mar 31, 2021 Investor + Media Contacts: Astellas Pharma Inc. Corporate Communications TEL: +81-3-3244-3201 FAX: +81-3-5201-7473 Astellas Gene Therapies US Media Contact: Cassie …See details»
News - Astellas Gene Therapies
Jan 9, 2023 Astellas and AviadoBio Announce Exclusive Option and License Agreement for Gene Therapy AVB-101 Targeting Frontotemporal Dementia and Other IndicationsSee details»
FOR PATIENTS & FAMILIES - Astellas Gene Therapies
Our priority is to weave patient and caregiver perspectives into the fabric of all that we do on a day-to-day basis. And we advocate for patients and families with the commitment, dedication …See details»
OUR PIPELINE - Astellas Gene Therapies
Astellas Gene Therapies is developing gene therapy for the treatment of Pompe disease. AT845 is an investigational gene therapy designed for the delivery of functional copies of the human …See details»
Astellas and Taysha Gene Therapies Announce Strategic …
Oct 24, 2022 - Taysha Gene Therapies is an emerging leader in the development of AAV gene therapies; new collaboration aimed at enhancing development of two of Taysha's novel …See details»